Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Read More…
Industry, Sector and Symbol
Industry Toilet preparations
Sub-IndustryHousehold Products
SectorConsumer Staples
Phone212-310-2000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$15.54 billion
Profitability
Miscellaneous
Employees34,500
Next Earnings Date1/31/2020 (Confirmed)
OptionableOptionable
Colgate-Palmolive (NYSE:CL) Frequently Asked Questions
What is Colgate-Palmolive's stock symbol?
Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."
How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?
Colgate-Palmolive announced a quarterly dividend on Thursday, January 9th. Stockholders of record on Thursday, January 23rd will be paid a dividend of $0.43 per share on Friday, February 14th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.43%. The ex-dividend date of this dividend is Wednesday, January 22nd. View Colgate-Palmolive's Dividend History.
How will Colgate-Palmolive's stock buyback program work?
Colgate-Palmolive declared that its board has initiated a share buyback plan on Monday, June 18th 2018, which authorizes the company to repurchase $5,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 9% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's management believes its shares are undervalued.
How were Colgate-Palmolive's earnings last quarter?
Colgate-Palmolive (NYSE:CL) issued its quarterly earnings data on Friday, November, 1st. The company reported $0.71 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.70 by $0.01. The firm had revenue of $3.93 billion for the quarter, compared to analyst estimates of $3.95 billion. Colgate-Palmolive had a net margin of 15.04% and a return on equity of 6,492.71%. The company's revenue was up 2.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.72 EPS. View Colgate-Palmolive's Earnings History.
When is Colgate-Palmolive's next earnings date?
How can I listen to Colgate-Palmolive's earnings call?
Colgate-Palmolive will be holding an earnings conference call on Friday, January 31st at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What price target have analysts set for CL?
14 brokerages have issued twelve-month price objectives for Colgate-Palmolive's shares. Their forecasts range from $58.00 to $82.00. On average, they anticipate Colgate-Palmolive's stock price to reach $73.08 in the next year. This suggests a possible upside of 3.1% from the stock's current price. View Analyst Price Targets for Colgate-Palmolive.
What is the consensus analysts' recommendation for Colgate-Palmolive?
14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 9 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Colgate-Palmolive.
What are Wall Street analysts saying about Colgate-Palmolive stock?
Here are some recent quotes from research analysts about Colgate-Palmolive stock:
- 1. According to Zacks Investment Research, "Shares of Colgate have declined and underperformed the industry in the past six months, driven by its strained margin trend. In third-quarter 2019, escalated expenses of raw and packaging materials, including foreign-currency transaction costs, hurt gross margin. This coupled with higher SG&A expenses, as a rate of sales, hurt operating profits. Consequently, earnings fell year over year and are likely to decline in mid-single digits in 2019. Also, adverse currency impacts cannot be ignored. Nevertheless, Colgate expects strong top-line gains from accelerated investments in brands, pricing and innovation along with expansion in new markets and e-commerce capabilities. Moreover, it expects to sustain organic sales growth trend in 2019, backed by higher volume and pricing. Management now estimates organic sales growth of 3-4%." (11/4/2019)
- 2. Wells Fargo & Co analysts commented, "We are raising our price target by $3 to $68 to reflect CL’s fundamental progress to date, but maintain our Market Perform rating largely on valuation." (6/17/2019)
Has Colgate-Palmolive been receiving favorable news coverage?
Press coverage about CL stock has trended extremely negative recently, according to InfoTrie. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Colgate-Palmolive earned a media sentiment score of -4.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Colgate-Palmolive.
Are investors shorting Colgate-Palmolive?
Colgate-Palmolive saw a decrease in short interest during the month of December. As of December 31st, there was short interest totalling 13,460,000 shares, a decrease of 5.5% from the December 15th total of 14,250,000 shares. Based on an average trading volume of 3,670,000 shares, the short-interest ratio is presently 3.7 days. Currently, 1.6% of the shares of the stock are short sold. View Colgate-Palmolive's Current Options Chain.
Who are some of Colgate-Palmolive's key competitors?
What other stocks do shareholders of Colgate-Palmolive own?
Who are Colgate-Palmolive's key executives?
Colgate-Palmolive's management team includes the folowing people:
- Mr. Ian M. Cook, Exec. Chairman (Age 66)
- Mr. Noel R. Wallace, Pres, CEO & Director (Age 55)
- Mr. Henning I. Jakobsen, Chief Financial Officer (Age 59)
- Mr. P. Justin Skala, Exec. VP and Chief Growth & Strategy Officer (Age 59)
- Dr. Patricia D. Verduin Ph.D., Chief Technology Officer (Age 60)
Who are Colgate-Palmolive's major shareholders?
Colgate-Palmolive's stock is owned by many different of institutional and retail investors. Top institutional investors include LGT Capital Partners LTD. (0.15%), PGGM Investments (0.10%), Boston Trust Walden Corp (0.07%), Gateway Investment Advisers LLC (0.06%), Manning & Napier Group LLC (0.04%) and Nisa Investment Advisors LLC (0.04%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Prabha Parameswaran and Stephen I Sadove. View Institutional Ownership Trends for Colgate-Palmolive.
Which institutional investors are selling Colgate-Palmolive stock?
CL stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Manning & Napier Group LLC, Tocqueville Asset Management L.P., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Gateway Investment Advisers LLC, Boston Trust Walden Corp, Nisa Investment Advisors LLC and Galibier Capital Management Ltd.. Company insiders that have sold Colgate-Palmolive company stock in the last year include Dennis J Hickey, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Noel R Wallace, Patricia Verduin, Philip G Shotts, Prabha Parameswaran and Stephen I Sadove. View Insider Buying and Selling for Colgate-Palmolive.
Which institutional investors are buying Colgate-Palmolive stock?
CL stock was bought by a variety of institutional investors in the last quarter, including LGT Capital Partners LTD., Pensionfund DSM Netherlands, Baxter Bros Inc., United Services Automobile Association, Townsend & Associates Inc, Johanson Financial Advisors Inc., Pensionfund Sabic and Bright Rock Capital Management LLC. View Insider Buying and Selling for Colgate-Palmolive.
How do I buy shares of Colgate-Palmolive?
Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Colgate-Palmolive's stock price today?
One share of CL stock can currently be purchased for approximately $70.91.
How big of a company is Colgate-Palmolive?
Colgate-Palmolive has a market capitalization of $60.77 billion and generates $15.54 billion in revenue each year. The company earns $2.40 billion in net income (profit) each year or $2.97 on an earnings per share basis. Colgate-Palmolive employs 34,500 workers across the globe.View Additional Information About Colgate-Palmolive.
What is Colgate-Palmolive's official website?
How can I contact Colgate-Palmolive?
Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]
MarketBeat Community Rating for Colgate-Palmolive (NYSE CL)
MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote "Outperform" if you believe CL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CL will underperform the S&P 500 over the long term. You may vote once every thirty days.
